AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Discounted Cash Flow (DCF) Analysis Unlevered

Dova Pharmaceuticals Inc. Quote

Dova Pharmaceut (DOVA)

7.50 -0.59 Healthcare
All | Operating Data | Balance Sheet Data | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results

Operating Data DOVA Quote Dova Pharma

Balance Sheet Data DOVA Quote Dova Pharma

Weighted Average Cost Of Capital DOVA Quote Dova Pharma

Share Price $ 7.5
Diluted Shares Outstanding 0
Cost of Debt
Tax Rate -
After-tax Cost of Debt -
Risk Free Rate
Market Risk Premium
Cost of Equity 10.47
Total Debt 0.00
Total Equity 157.50
Total Capital 157.50
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash DOVA Quote Dova Pharma

Terminal Value DOVA Quote Dova Pharma

Growth in perpetuity method:
Long term growth rate
WACC (%) 10.5
Free cash flow (t+1) 0.00
Terminal Value 0.00
Present Value of Terminal Value 0.00

Intrinsic Value DOVA Quote Dova Pharma

Enterprise Value -
Net Debt -95
Equity Value -
Shares Outstanding 21
Equity Value Per Share -

Results Unlevered DCF DOVA Quote Dova Pharma